About Microquin

Reenvisioning Hope at the Cellular Level

Founded in London (United Kingdom) in 2016, MicroQuin was born out of a collaborative and inclusive approach to research. MicroQuin is a biotechnology, R&D based company currently focusing on developing therapeutics to address a range of oncological disease. MicroQuin is progressing lead compounds into clinical trials, which offer a potential cure to Breast Cancer and other diseases.

Contact Microquin

More About Microquin

Therapeutic Areas
  • Autoimmune disorders
  • Oncology
  • Drug delivery
  • Peptides
  • Other
Company Type
  • Biotechnology – R&D services
State of Ownership
  • Private
Sponsorship Group
  • Networker
Go to the profile of Carmen Ramirez

Carmen Ramirez

Sales Account Executive, Springer Nature

Go to the profile of Albany A. Cordova Martins

Albany A. Cordova Martins

Business Development Executive, Nature Publishing Group, Springer Nature